9-Aminocamptothecin glucuronide, 9-ACG
Chemical Name: 1-O-[4-[N-[4(S)-Ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-10-yl]carbamoyloxymethyl]phenyl]-beta-D-glucuronic acid
CAS No. 246032-57-5, 246032-60-0 (K salt)
项目整合开发状态: Preclinical
项目研究机构: Academia Sinica (Originator)
合成路线:Treatment of (20S)-camptothecin (I) with HOAc and H2O2 followed by light irradiation in H2SO4 yields hydroxy derivative (II),which is then nitrated by means of HNO3 and H2SO4 to afford compound (III).Sulfonation of (III) by reaction with p-TsCl (IV) in the presence of Et3N and DMAP in CH2Cl2 provides sulfonate (V),which is then subjected to reduction by treatment with Pd(OAc)2,PPh3 and triethylammoniumformate (HCOOH稥t3N) to give 9-aminocamptothecin (VI).Reaction of (VI) with nitrophenyl chloroformate (VII) in dioxane,followed by treatment with intermediate (VIII) and DMAP in acetonitrile,provides (IX).Alternatively,(IX) can also be obtained by first treatment of (VI) with triphosgene followed by reaction with intermediate (VIII) in pyridine and chromatographic purification.Finally,(IX) is treated with potassium trimethyl silanate (KOSiMe3) for methyl ester cleavage and acidified with HCl.
合成路线:Intermediate (VIII) can be obtained as follows: Bromination of glucuronate derivative (X) by means of TiBr4 in CH2Cl2 followed by reaction with p-hydroxybenzaldehyde (XI) in acetonitrile in the presence of Ag2O affords derivative (XII),whose aldehyde moiety is then reduced by means of NaBH4 and silica gel in isopropanol/CHCl3 to provide benzyl alcohol (XIII).Finally,O-acetyl groups of (XIII) are cleaved by means of NaOMe in MeOH to furnish intermediate (VIII).
合成路线:Treatment of glucuronic acid gamma-lactone (I) with sodium methoxide in methanol affords methyl glucuronate (II),which is further acylated by acetic anhydride to form the tetraacetate ester (III).Bromination of (III) with TiBr4,followed by coupling of the resultant bromide (IV) with p hydroxybenzaldehyde (V) in the presence of Ag2O yields the peracetylated glucuronide (VI).Aldehyde (VI) reduction employing NaBH4 in the presence of silica gel leads to the benzyl alcohol (VII).The acetate ester groups of (VII) are then removed with sodium methoxide in methanol to furnish (VIII).
合成路线:10-Hydroxycamptothecin (IX) is nitrated with HNO3/H2SO4 and the resulting 9-nitro-10-hydroxycamptothecin (X) is treated with tosyl chloride to form the tosylate (XI).Palladium-catalyzed reduction of nitro tosylate (XI) gives rise to 9-aminocapmtothecin (XII).Amine (XII) is activated as the isocyanate (XIII) upon treatment with triphosgene (1) or alternatively as the aryl carbamate (XIV) employing p-nitrophenyl chloroformate.Coupling of either isocyanate (XIII) or carbamate (XIV) with p-hydroxybenzyl alcohol glucuronide (VIII) leads to adduct (XV).The methyl glucuronate ester (XV) is finally hydrolyzed to the target acid under anhydrous conditions by using potassium trimethylsilanolate.
📌 参考资料/链接:
参考文献标题:Proactive antitumor cpds.
文献作者:Chern,J.-W.; Roffler,S.; Leu,Y.-L.(Academia Sinica)
参考来源:EP 0990661; US 6043367
📄 详细内容
合成路线:Treatment of (20S)-camptothecin (I) with HOAc and H2O2 followed by light irradiation in H2SO4 yields hydroxy derivative (II),which is then nitrated by means of HNO3 and H2SO4 to afford compound (III).Sulfonation of (III) by reaction with p-TsCl (IV) in the presence of Et3N and DMAP in CH2Cl2 provides sulfonate (V),which is then subjected to reduction by treatment with Pd(OAc)2,PPh3 and triethylammoniumformate (HCOOH稥t3N) to give 9-aminocamptothecin (VI).Reaction of (VI) with nitrophenyl chloroformate (VII) in dioxane,followed by treatment with intermediate (VIII) and DMAP in acetonitrile,provides (IX).Alternatively,(IX) can also be obtained by first treatment of (VI) with triphosgene followed by reaction with intermediate (VIII) in pyridine and chromatographic purification.Finally,(IX) is treated with potassium trimethyl silanate (KOSiMe3) for methyl ester cleavage and acidified with HCl.
合成路线:Intermediate (VIII) can be obtained as follows: Bromination of glucuronate derivative (X) by means of TiBr4 in CH2Cl2 followed by reaction with p-hydroxybenzaldehyde (XI) in acetonitrile in the presence of Ag2O affords derivative (XII),whose aldehyde moiety is then reduced by means of NaBH4 and silica gel in isopropanol/CHCl3 to provide benzyl alcohol (XIII).Finally,O-acetyl groups of (XIII) are cleaved by means of NaOMe in MeOH to furnish intermediate (VIII).
合成路线:Treatment of glucuronic acid gamma-lactone (I) with sodium methoxide in methanol affords methyl glucuronate (II),which is further acylated by acetic anhydride to form the tetraacetate ester (III).Bromination of (III) with TiBr4,followed by coupling of the resultant bromide (IV) with p hydroxybenzaldehyde (V) in the presence of Ag2O yields the peracetylated glucuronide (VI).Aldehyde (VI) reduction employing NaBH4 in the presence of silica gel leads to the benzyl alcohol (VII).The acetate ester groups of (VII) are then removed with sodium methoxide in methanol to furnish (VIII).
合成路线:10-Hydroxycamptothecin (IX) is nitrated with HNO3/H2SO4 and the resulting 9-nitro-10-hydroxycamptothecin (X) is treated with tosyl chloride to form the tosylate (XI).Palladium-catalyzed reduction of nitro tosylate (XI) gives rise to 9-aminocapmtothecin (XII).Amine (XII) is activated as the isocyanate (XIII) upon treatment with triphosgene (1) or alternatively as the aryl carbamate (XIV) employing p-nitrophenyl chloroformate.Coupling of either isocyanate (XIII) or carbamate (XIV) with p-hydroxybenzyl alcohol glucuronide (VIII) leads to adduct (XV).The methyl glucuronate ester (XV) is finally hydrolyzed to the target acid under anhydrous conditions by using potassium trimethylsilanolate.
参考文献标题:Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT)
文献作者:Leu,Y.L.; Roffler,S.R.; Chern,J.-W.
参考来源:J Med Chem 1999,42(18),3623
合成路线:The hydroxylation of camptothecin (I) with H2O2 in HOAc gives 10-hydroxycamptothecin (II),which is nitrated with HNO3/H2SO4 to yield 10-hydroxy-9-nitrocamptothecin (III).The sulfonation of (III) with TsCl,DEA and DMAP affords 9-nitro-10-p-toluenesulfonyloxy)camptothecin (IV),which is finally desulfonated and reduced by means of ammonium formate and a Pd(OAc)3/bidentate phosphine ligand catalyst.Other sulfonates such as 1-naphthyl-,phenyl-,4-fluorophenyl-,4-nitrophenyl-,4-methoxyphenyl- or methylsulfonate can be used instead of the reported p-toluenesulfonate.
合成路线:Treatment of (20S)-camptothecin (I) with HOAc and H2O2 followed by light irradiation in H2SO4 yields hydroxy derivative (II),which is then nitrated by means of HNO3 and H2SO4 to afford compound (III).Sulfonation of (III) by reaction with p-TsCl (IV) in the presence of Et3N and DMAP in CH2Cl2 provides sulfonate (V),which is then subjected to reduction by treatment with Pd(OAc)2,PPh3 and triethylammoniumformate (HCOOH稥t3N) to give 9-aminocamptothecin (VI).Reaction of (VI) with nitrophenyl chloroformate (VII) in dioxane,followed by treatment with intermediate (VIII) and DMAP in acetonitrile,provides (IX).Alternatively,(IX) can also be obtained by first treatment of (VI) with triphosgene followed by reaction with intermediate (VIII) in pyridine and chromatographic purification.Finally,(IX) is treated with potassium trimethyl silanate (KOSiMe3) for methyl ester cleavage and acidified with HCl.
参考文献标题:A new high yield semisynthetic approach to (20S)-9-NH2-camptothecin based on a sequence of palladium-catalysed reductions
文献作者:Cabri,W.; et al.
参考来源:Tetrahedron Lett 1995,36(50),9197